Sulla via del Dolore - The path of Pain
The studies conducted on the employment of the analgesic drug have considered that drugs that had the ability to decrease the firing of impulses that from the periphery they are propagated to the brain. After the cloning of TRPV1,1,2 occurred in the last ten years of research, the focus has shift...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Publiediting
2017-01-01
|
Series: | Pathos |
Subjects: | |
Online Access: | https://www.pathos-journal.com/2016_3_173.html |
id |
doaj-6b392e783f804f9898229ead01217174 |
---|---|
record_format |
Article |
spelling |
doaj-6b392e783f804f9898229ead012171742020-11-24T22:54:59ZengPublieditingPathos1593-23542385-07442017-01-01233Sulla via del Dolore - The path of PainFrancesco Amato0 Erminia Gilda Morrone1Direttore UOC Ter Dolore e CP AO Cosenza Centro Hub Regionale Biologa, Associazione Centro Studi Terapia del Dolore CosenzaThe studies conducted on the employment of the analgesic drug have considered that drugs that had the ability to decrease the firing of impulses that from the periphery they are propagated to the brain. After the cloning of TRPV1,1,2 occurred in the last ten years of research, the focus has shifted to the Transient Receptor Potential (TRPV1) which sees them involved in many inflammatory and neuropathic processes. For these reasons TRPV1 has become a viable drug target for clinical use in the management of pain. This short review will provide a general picture of the physiological and pathophysiological roles of the TRPV1 channel and of their structural, pharmacological and biophysical properties, as therapeutic agents for the management of chronic and neuropathic pain.https://www.pathos-journal.com/2016_3_173.htmlIon channelsTRPV1painanalgesianeuropathic infiammation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Francesco Amato Erminia Gilda Morrone |
spellingShingle |
Francesco Amato Erminia Gilda Morrone Sulla via del Dolore - The path of Pain Pathos Ion channels TRPV1 pain analgesia neuropathic infiammation |
author_facet |
Francesco Amato Erminia Gilda Morrone |
author_sort |
Francesco Amato |
title |
Sulla via del Dolore - The path of Pain |
title_short |
Sulla via del Dolore - The path of Pain |
title_full |
Sulla via del Dolore - The path of Pain |
title_fullStr |
Sulla via del Dolore - The path of Pain |
title_full_unstemmed |
Sulla via del Dolore - The path of Pain |
title_sort |
sulla via del dolore - the path of pain |
publisher |
Publiediting |
series |
Pathos |
issn |
1593-2354 2385-0744 |
publishDate |
2017-01-01 |
description |
The studies conducted on the employment of the analgesic drug have considered that drugs that had the ability to decrease the firing of impulses that from the periphery they are propagated to the brain. After the cloning of TRPV1,1,2 occurred in the last ten years of research, the focus has shifted to the Transient Receptor Potential (TRPV1) which sees them involved in many inflammatory and neuropathic processes. For these reasons TRPV1 has become a viable drug target for clinical use in the management of pain. This short review will provide a general picture of the physiological and pathophysiological roles of the TRPV1 channel and of their structural, pharmacological and biophysical properties, as therapeutic agents for the management of chronic and neuropathic pain. |
topic |
Ion channels TRPV1 pain analgesia neuropathic infiammation |
url |
https://www.pathos-journal.com/2016_3_173.html |
work_keys_str_mv |
AT francescoamato sullaviadeldolorethepathofpain AT erminiagildamorrone sullaviadeldolorethepathofpain |
_version_ |
1725658444480905216 |